Delivery Order SPE2DX22D0010-SPE2D824FDY05
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $109,867.10 firm fixed-price delivery order contract has an ultimate completion date of July 8, 2025. The award provides for the supply of a range of pharmaceutical products and medical supplies, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This...
- This federal contract award, valued at $1,347.36, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), which is a $999,999,999.00 prime contract that enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs...
- This is a $954,576.36 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award, valued at $1,261,394.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of March 24, 2025. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies, including medications across various therapeutic domains such as diabetes...
- This federal contract award is a Delivery Order valued at $30,176.64 issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), with the ultimate completion date of June 10, 2025. The contract is for the provision of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across...
- This federal contract award, SPE2DX22D0020|SPE2D824F09VS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $792,660.92 firm-fixed-price delivery order contract has an ultimate completion date of December 14, 2023. The contract is not set-aside and provides for the delivery of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic...
- This federal contract award, valued at $503,382.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order covers a range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,781.62 Delivery Order contract is for the provision of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, antibiotics, and specialized...
- This federal contract award, valued at $826,966.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the DLA's Troop Support Medical Indefinite Delivery Contract (IDC), which is a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The contract involves the delivery of a wide range of...
- This federal contract award, valued at $942,503.67, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, and a performance period ending on March 31, 2025. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs, including medications across various therapeutic areas such as diabetes,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FDY05Delivery Order
This federal contract award, with ID SPE2DX22D0010|SPE2D824FDY05, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $501,535.29 delivery order contract is for the provision of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and specialized medical supplies. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is not set aside for any specific business type, indicating open competition. The ultimate completion date for this award is December 4, 2023.